“Not only is TRHC combining DoseMe’s state-of-the-art decision support tool with our ability to predict and prevent harmful drug interactions through tools such as the MRM Matrix®, which we are now able to offer hospitals, we have added two exceptional executives to our ranks. “What a terrific way to start 2019,” said TRHC’s Chairman and CEO Calvin H. McLeay founded DoseMe in 2012 where he combined his experience in modelling biological data and delivering large information technology projects with the goal of providing access to best-practice precision dosing via easy-to-use software designed for clinical practice. Cornish also has served as a director of various corporate boards. Cornish’s background encompasses more than 20 years in various medical devices, pharmaceuticals, healthcare consumables, funds management and management consulting roles throughout North America, Europe, South America and Asia Pacific progressing from sales and marketing, strategy and finance to CEO. McLeay will remain located at DoseMe’s offices in Brisbane, Australia. Robert McLeay, Ph.D, Founder of DoseMe, also will remain with DoseMe and will serve as Chief Scientific Officer of DoseMe. DoseMe is the developer of DoseMeRx, an advanced precision dosing tool that helps physicians and pharmacists accurately dose patients’ high-risk parenteral medications based on individual needs, resulting in significant improvements to mortality, risk, and patient outcomes.ĭoseMeRx’s precision dosing capabilities will combine with TRHC’s proprietary Medication Risk Mitigation (MRM) technologies to enhance and accelerate medication safety solutions and will be made available to the hospital healthcare system market and internationally.Ĭharles Cornish, the Chief Executive Officer of DoseMe, will retain his position following the completion of the acquisition and will be relocating to TRHC’s headquarters in Moorestown, NJ. (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced that it completed its acquisition of precision dosing software company DoseMe on January 2, 2019. 07, 2019 (GLOBE NEWSWIRE) - Tabula Rasa HealthCare, Inc.
0 Comments
Leave a Reply. |